Home›People›Allan Green
AG

Allan Green

Director at Ratio Therapeutics.

Director
Updated Nov 9, 2026·Latest SEC filing Jul 31, 2026·Suggest an edit

About Allan Green

Allan Green is a director at Ratio Therapeutics.

Allan Green first appears on SEC filings in 2023.

Experience

This experience comes from Allan Green's profile and from SEC filings. For roles taken from filings, the years are when the filings name Allan Green in the role, so the role may have started earlier or lasted longer.

Ratio Therapeutics, Inc. Current
Director
2021 – Present · Boston, MA
Develops targeted radioactive medicines for people with cancer.
SDG, LLC Current
Co-Managing Director
2006 – Present
PSMA Therapeutics
Executive Vice President PSMA Therapeutics, Inc.
2020 – 2022
Noria Therapeutics Inc
President
2017 – 2021
Ground Fluor Pharmaceuticals, Inc.
President
2012 – 2020
Alzheimer's Drug Discovery Foundation
External Counsel
2005 – 2014

Key Colleagues at Startups

The people Allan Green works with at each company, as listed on that company's latest Form D.

Ratio Therapeutics, Inc. · Form D, Jul 31, 2026
SM
Scott MacDonald
Executive officer
MB
Marc Becker
Chief Financial Officer and Chief Operating Officer
AH
WC
JH
John Hoppin
Chief Executive Officer and director
JB
John Babich
Chief Scientific Officer and director
SW

Sources

  1. SECRatio Therapeutics, Inc. Form D, filed Jul 31, 2026